RxDoctor Payments Data

Rick Waks, DO

Family Medicine · Fort Myers, FLNPI 1194726091

Payments from drug & device makers

$863in general payments, 2019–2025

Across 22 payments — averaging $39.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$186
  • Johnson & Johnson$138
  • W. L. Gore & Associates, Inc.$94
  • Dexcom, Inc.$90
  • Novo Nordisk$87
  • E.r. Squibb & Sons, L.L.C.$85
  • plus $183 from 6 others

What the payments were for

  • Food & beverage$863100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$863 in reported general payments places this provider in the 60th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$230,672
Medicare patients
552
Services billed
4,333

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide103$123,206
JardianceEmpagliflozin50$59,740
EliquisApixaban54$50,013
XareltoRivaroxaban35$31,583
JanumetSitagliptin Phos/Metformin Hcl18$30,696
MounjaroTirzepatide27$30,225
JanuviaSitagliptin Phosphate20$27,682
Janumet XrSitagliptin Phos/Metformin Hcl16$15,194
MyrbetriqMirabegron23$12,309
Fiasp FlextouchInsulin Aspart (Niacinamide)11$6,412
Atorvastatin Calcium737$5,610
Rosuvastatin Calcium435$4,227
SynthroidLevothyroxine Sodium45$3,768
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$3,644
Levemir FlexpenInsulin Detemir12$2,967

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$87$123,206103 claims
MerckJanumet, Januvia, Janumet Xr$11$73,57254 claims
PfizerEliquis$22$50,01354 claims
Johnson & JohnsonXarelto$138$31,58335 claims
Lilly USA, LLCMounjaro$81$30,22527 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Fort Myers

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →